• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Haemostasis in patients with Behçet's disease.

作者信息

Demirer S, Sengül N, Yerdel M A, Tüzüner A, Ulus A T, Gürler A, Bergqvist D, Siegbahn A, Karacagil S

机构信息

Department of Surgery, Ankara University Hospital, Turkey.

出版信息

Eur J Vasc Endovasc Surg. 2000 Jun;19(6):570-4. doi: 10.1053/ejvs.2000.1091.

DOI:10.1053/ejvs.2000.1091
PMID:10873722
Abstract

AIM

to determine whether Behçet's disease affects haemostatic function.

SETTING

University Hospital, Turkey.

PATIENTS

one hundred and twenty-seven consecutive patients with Behçet's disease, 34 of whom with a history of vascular involvement.

METHODS

prothrombin fragment 1+2 tissue plasminogen activator, protein S and C, antithrombin, fibrinogen, von Willebrand factor, thrombomodulin and prothrombin time (PT) were measured in patient plasma.

RESULTS

soluble thrombomodulin was significantly lower and von Willebrand factor (vWF) and tissue plasminogen activator (tPA) significantly higher in Behçet's patients. Patients with vascular involvement showed the highest levels of vWF and tPA. There was no activation of coagulation, not even in patients with an active disease at the time of sampling.

CONCLUSION

there were indirect signs of endothelial activity or damage, particularly in patients with vascular involvement. Coagulation was not activated.

摘要

相似文献

1
Haemostasis in patients with Behçet's disease.
Eur J Vasc Endovasc Surg. 2000 Jun;19(6):570-4. doi: 10.1053/ejvs.2000.1091.
2
Endothelial cell activation and hypercoagulability in ocular Behçet's disease.眼部白塞病中的内皮细胞活化与高凝状态
Am J Ophthalmol. 2004 May;137(5):850-7. doi: 10.1016/j.ajo.2003.12.010.
3
Von Willebrand factor antigen levels in Behçet disease.白塞病中的血管性血友病因子抗原水平。
Am J Hematol. 2005 May;79(1):70-2. doi: 10.1002/ajh.20317.
4
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.晚期慢性心力衰竭中的止血和炎症生物标志物:口服抗凝剂和心脏移植成功的作用
Br J Haematol. 2004 Jul;126(1):85-92. doi: 10.1111/j.1365-2141.2004.04977.x.
5
Coagulation and fibrinolytic activity in Behçet's disease.白塞病中的凝血和纤溶活性。
Thromb Haemost. 1991 Sep 2;66(3):292-4.
6
[Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].[血管性白塞病患者的血浆凝血和纤维蛋白溶解参数以及血管性血友病因子(vWF)多聚体结构分析]
Ryumachi. 1993 Oct;33(5):416-23.
7
Activated protein C levels in Behçet's disease and risk of venous thrombosis.白塞病中活化蛋白C水平与静脉血栓形成风险
Br J Haematol. 2004 Aug;126(4):550-6. doi: 10.1111/j.1365-2141.2004.05072.x.
8
Von Willebrand factor in Behçet's syndrome.白塞病中的血管性血友病因子
J Rheumatol. 1987 Apr;14(2):305-6.
9
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.白塞病中的血管受累:与血栓形成倾向因素、凝血激活及血栓调节蛋白的关系。
Am J Med. 2002 Jan;112(1):37-43. doi: 10.1016/s0002-9343(01)01048-8.
10
Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.高纯度尿促卵泡素和重组促卵泡素对止血的影响:一项开放标签、随机对照试验。
Hum Reprod. 2004 Apr;19(4):838-48. doi: 10.1093/humrep/deh185. Epub 2004 Mar 11.

引用本文的文献

1
Plasma Levels of ADAMTS-13 Antigen, ADAMTS-13 Inhibitor, ADAMTS-13 Activity, and Von Willebrand Factor in Patients with Behçet's Disease.白塞病患者血浆中ADAMTS-13抗原、ADAMTS-13抑制剂、ADAMTS-13活性及血管性血友病因子水平
Mediterr J Rheumatol. 2024 Nov 7;36(1):73-78. doi: 10.31138/mjr.020524.pla. eCollection 2025 Mar.
2
Evaluation of inflammatory-thrombosis panel as a diagnostic tool for vascular Behçet's disease.评估炎症-血栓形成指标作为血管性白塞病的诊断工具
Clin Rheumatol. 2025 Mar;44(3):1279-1291. doi: 10.1007/s10067-025-07301-6. Epub 2025 Jan 31.
3
Oral Lesions as the Primary Manifestations of Behçet's Disease: The Importance of Interdisciplinary Diagnostics-A Case Report.
以口腔病变为主要表现的白塞病:多学科诊断的重要性——病例报告
Biomedicines. 2023 Jul 3;11(7):1882. doi: 10.3390/biomedicines11071882.
4
Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations.利用来自两个不同人群的全基因组关联研究数据鉴定白塞病中可能的致病途径。
Eur J Hum Genet. 2015 May;23(5):678-87. doi: 10.1038/ejhg.2014.158. Epub 2014 Sep 17.
5
Haemostatic Parameters in Patients with Behçet's Disease.白塞病患者的止血参数
Sultan Qaboos Univ Med J. 2014 May;14(2):e190-6. Epub 2014 Apr 7.
6
Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.白塞病:促凝状态、内皮激活/损伤与疾病活动之间关系的新认识。
Orphanet J Rare Dis. 2013 May 27;8:81. doi: 10.1186/1750-1172-8-81.
7
Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.白塞病:心血管受累的新概念及治疗的未来方向
ISRN Pharmacol. 2012;2012:760484. doi: 10.5402/2012/760484. Epub 2012 Mar 8.
8
Behçet's Disease as a Model of Venous Thrombosis.白塞病作为静脉血栓形成的模型
Open Cardiovasc Med J. 2010 Feb 23;4:71-7. doi: 10.2174/1874192401004020071.
9
Decreased protein S activity is related to the disease activity of Behcet's disease.蛋白S活性降低与白塞病的疾病活动度相关。
Rheumatol Int. 2006 Nov;27(1):39-43. doi: 10.1007/s00296-006-0214-4. Epub 2006 Sep 13.
10
Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.白塞病患者血清中血管内皮生长因子和碱性成纤维细胞生长因子水平
Rheumatol Int. 2005 Oct;25(8):599-603. doi: 10.1007/s00296-004-0484-7. Epub 2004 Jul 15.